SC 13G Filing

Company

Innate Pharma SA

Filed

October 23, 2019

Accession Number

0000935836-19-000556

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →